The HealthTech Signal
JawBuddy logo

JawBuddy

Digital support for jaw pain, bruxism and craniomandibular dysfunction.

jawbuddy.de

What they do

JawBuddy announced €818,000 in pre-seed financing on November 4, 2026, led by HALBZEIT. The total includes the Sächsische Aufbaubank Business Angel Bonus, not only private equity. Its release describes Class I MDR registration and a planned 130-patient multicentre randomized trial starting in December 2026. The trial is planned, not completed; no USD conversion is supplied.

Source announcement

People in this update

  • Leon RauchCo-founder and CEOSource
  • Moritz SchererCo-founderSource
  • Benjamín Cádiz de GraciaCo-founderSource

The record

Vertical
Primary & Virtual Care
Sub-segment
Jaw pain and bruxism
Product type
Software as a medical device
Stage
Pre-seed
Headquarters
Leipzig, Germany
Region
Europe
Founded
Not disclosed
Total funding
Undisclosed

Notable investors: HALBZEIT.

Also in Primary & Virtual Care

See the Primary & Virtual Care market map

Related on The Signal

Keep exploring